Zacks Investment Research on MSN
MNMD stock up more than 100% in 6 months: What's in store for 2026?
MNMD is developing its lead pipeline candidate MM120, an orally disintegrating tablet (ODT) and a pharmaceutically optimized form of lysergide D-tartrate, for the treatment of generalized anxiety ...
Mental health has moved from the margins to the center of the global healthcare conversation. Rising anxiety, depression, and ...
MindMed (NASDAQ:MNMD) stock isn’t doing so hot with shares taking a beating on the first day of trading at their new home. Unfortunately, that plan doesn’t seem to be going well today. Shares of MNMD ...
MindMed (OTCMKTS:MMEDF) stock has been climbing recently in anticipation of its uplisting on the Nasdaq Exchange this week, where it will trade as MNMD stock. The company’s announcement that it will ...
Inc.’s stock price changed recently Before we jump into Mind Medicine (MindMed) Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background. Mind ...
You heard that right. Psychedelic treatment and therapy options may be coming to a pharmacy near you. Investors are getting hyped as the company’s experimental drug passes through clinical trials. Yet ...
If You'd Invested $1,000 in Mind Medicine (MNMD) Stock 5 Years Ago, Here's How Much You'd Have Today
Mind Medicine stock is a speculative play on future potential for psychedelics as therapeutic treatments. The stock has underperformed the S&P 500 over the last five years, but it has still delivered ...
MindMed (NASDAQ:MNMD) stock is getting a boost on Monday following news from the U.S. Food and Drug Administration (FDA). The news that has MNMD stock higher today is a Type C Meeting Responses from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback